COMMUNIQUÉS West-GlobeNewswire
-
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
17/04/2026 -
Kailera Therapeutics Announces Pricing of Initial Public Offering
17/04/2026 -
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
17/04/2026 -
OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research
16/04/2026 -
Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto
17/04/2026 -
TerrAscend Appoints Eric Jackson as Chief Financial Officer
16/04/2026 -
OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
16/04/2026 -
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
16/04/2026 -
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
16/04/2026 -
LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026
16/04/2026 -
VapoFil Under Investigation: Evaluating the Vapor Rub Male Enhancement Honey Trick Claims
16/04/2026 -
Extendicare Announces Voting Results for its 2026 Annual Meeting of Shareholders
17/04/2026 -
JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
17/04/2026 -
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems
16/04/2026 -
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
16/04/2026 -
Raw Garden 4/20 Deals: Up to 60% Off California Cannabis
17/04/2026 -
Globus Medical Schedules First Quarter Earnings Release and Conference Call
16/04/2026 -
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
16/04/2026 -
Trevi Therapeutics Announces Proposed Public Offering of Common Stock
16/04/2026
Pages